INSIGHTS ON PHARMACEUTICAL PACKAGING

• The Effect Of Conventional Cooling Versus Controlled Ice Nucleation On Primary Drying Time

  See how controlled ice nucleation shortens lyophilization cycles, supports higher drying temperatures, and reduces complexity for amorphous and mixed formulations without sacrificing quality.

• Quick View Of Asymchem's New OEB5 Facility

  Explore Asymchem’s OEB5 high-potency facility — a 6,000 m², fully enclosed site integrating R&D, manufacturing, and analytics under CPT ≤1 ng/m³ containment.

• Asymchem's State-Of-The-Art HTE Platform

  Steve Fussell, Senior Manager – High-Throughput Experimentation (HTE) at Asymchem, introduces our state-of-the-art HTE laboratory, where automation, robotics, and data-driven insights transform process R&D.

• ATLAS Label Translation Solution

  By simplifying label requests, integrating expert translation and regulatory support, and enabling a fully paperless approval workflow, organizations can reduce turnaround times while maintaining high-quality label content.

• Advancing Health Through Decades Of Packaging Innovation

  2/27/2026

  A legacy of packaging expertise evolved into a mission centered on helping life‑changing medicines reach people. See how purpose, curiosity, and partnership drive continued growth.

• What To Look For In A Pharma Contract Packaging Partner

  2/27/2026

  Teams face rising pressure around compliance, complexity, and speed. These five essential qualities help identify packaging partners who can support production, reduce risk, and align with your needs.

• Choosing The Right Pharma CMO: The 3 Cs That Matter Most

  2/27/2026

  Choosing a CMO is a strategic decision that shapes long‑term quality and scalability. Discover how a focused framework helps teams identify partners that can adapt and support growing portfolios.

• Robotics And AI In Pharma: Driving The Next Wave Of Innovation

  2/23/2026

  Adopting AI and robotics enhance sterility and regulatory compliance and enable real-time decision-making and reduce human-borne contamination, ensuring the safe production of complex therapies.